Skip to main content
our twitterour facebook page
My Example ***ALERT*** NYSE - OGEN: Oragenics, Inc. - Currently trading under $6.00


Oragenics, Inc. (NYSE American: OGEN)
Oragenics, Inc. represents a compelling investment opportunity with its forwardthinking leadership and cutting edge technology.  Oragenics is set to make waves in the market. Oragenics recently expanded its portfolio to encompass neurological drug therapies and technologies via the acquisition and partnership with Odyssey Health, Inc.

This strategic move positions Oragenics at the forefront of healthcare innovation, making it an attractive prospect for healthcare investors. Oragenics is also emerging as a big player in the field of lantibiotic and is responsible for Mutacin 1140 (MU1140), a groundbreaking lantibiotic, and over 700 analogs engineered, manufactured, and tested for safety, toxicity, stability, manufacturability, and drug activity.

Trading at under $3.00 per share and a very well structured share count,  this company remains a tremendous bargain and a huge opportunity for profits at this undervalued level.


Smallcap Stocks, Small Cap Stocks, Micro Cap Stocks, Nasdaq Stocks, NYSE stocks, OTC PINK SHEET STOCKS, OTC MARKET, OTCQB, Stock picks, Investor research, 
Day Trading, Day Traders, Stock Picks, Stock Picks, Microcap Daily, Investorplace, Investors hangout, otcmarkets, nasdaq stocks, nasdaq stock winners, stock charts, OTCQB stocks, low priced stocks, cheap stocks, big gains,

Stock Alerts, Penny stock alerts, penny stock picks, microcap stock picks, undiscovered stocks, under the radar stocks

    our twitterour facebook page
    Small Cap Corner

    Spotlighting Small Cap companies with solid foundations and long term potential.